[Ebook ENG] Anesthesia-Crisis

34 48. Mertes PM, Demoly P, Malinovsky JM. Hyper-sensitivity reactions in the anesthesia setting/allergic reactions to anesthetics. Curr Opin Allergy Clin Immunol 2012; 12(4): 361. 49. Nel L, Eren E. Peri-operative anaphylaxis. Br J Clin Pharmacol 2011; 71(5): 647-58. 50. American society of regional anesthesia and pain medicine. Checklist for the treatment of local anesthetic systemic toxicity (LAST) [Internet]. Philadelphia: American society of regional anesthesia and pain medicine; 2018 [cited 2019 Aug 12]. Available from: https://www.asra.com/content/documents/asra_last_checklist_2018.pdf 51. Christie LE, Picard J, Weinberg GL. Local anaesthetic systemic toxicity. BJA Education 2014; 15(3): 136-42. 52. Gupta PK, Hopkins PM. Diagnosis and management of malignant hyperthermia. BJA Education 2017; 17(7): 249-54. 53. Dudzinski DM, Piazza G. Multidisciplinary Pulmonary Embolism Response Teams. Cir-culation 2016; 133: 98. 54. Ellison DH, Felker GM. Diuretic treatment in heart failure. N Engl J Med 2017; 377: 1964-75. 55. Kabrhel C, Rosovsky R, Channick R, Jaff MR, Weinberg I, Sundt T, et al. A Multi-disciplinary Pulmonary Embolism Response Team: Initial 30-Month Experience with a Novel Approach to Delivery of Care to Patients with Submassive and Massive Pulmonary Embolism. Chest 2016; 150(2): 384-93. 56. Wentowski C, Mewada N, Nielsen ND. Sepsis in 2018: a review. Anaesthesia & Intensive Care Medicine 2019; 20(1): 6-13. 57. Dodick T, Greenberg S, O’Connor M. New Developments for the Management of Sepsis. Anesthesia Patient Safety Foundation 2016; 31(1): 1-7. [Cite 22 Sep 2019]. Available from: https://www.apsf. org/wp-content/uploads/newsletters/2016/June/pdf/APSF201606.pdf 58. Myburgh JA, Chapman MJ, Szekely SM, Osborne GA. Crisis management during anaesthesia: sepsis. Qual Saf Health Care 2005; 14(3): e22. 59. Nunnally ME. Sepsis for the anaesthetist. Br J Anaesth 2016; 117(suppl 3): iii44-iii51. 60. Overgaard CB, Dzavik V. Inotropes and vasopressors: review of physiology and clinical use in cardiovascular disease. Circulation 2018; 118(10): 1047-56. 61. Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, et al. Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock 2021. Crit Care Med 2021;49:e1063-143. doi: 10.1097/CCM.0000000000005337. 62. Yuki K, Murakami N. Sepsis pathophysiology and anesthetic consideration. Cardiovasc Hematol Disord Drug Targets 2015; 15(1): 57-69. 63. Faed J. Guidelines for management of adverse transfusion reactions [Internet]. 2014 [cited 2019 Sept 23]. Available: https://www.nzblood.co.nz/assets/Transfusion-Medicine/PDFs/ Guidelines-forManagement-of-Adverse-Transfusion-Reactions-111I015.pdf 64. Sahu S, Hemlata, Verma A. Adverse events related to blood transfusion. Indian J Anaesth 2014; 58(5): 543-51.